When Bridgewater resident Patricia Guest stumbled upon an unresponsive raccoon in her back yard, she didn’t hesitate to jump into action: “I own a pet-sitting business and I work in rescue. I’ve been around animals my whole life; it’s my nature to help animals in need.”
After putting on gloves, she gently pushed the animal into a box before transporting it to her car to AnimERge, a 24-hour veterinary hospital in Raritan. Staff members told her that the animal had the potential to be rabid and that they would be sending it to a lab for testing. They gave her a document about what her next steps should be. “I have to admit, I didn’t read it right away,” Guest said.
What she should have done is gone for treatment for her and her four dogs the next day. Four days later, Guest was informed by the New Jersey Department of Health that the raccoon that she touched had tested positive for rabies, and that she and her dogs needed to be treated as soon as possible.
Guest received the Post-Exposure Prophylactic Regimen (PEP), which includes one initial shot, immune-globulin injections based on the patient’s weight, and three additional shots in the days following. “Most people think that the vaccines are getting shots in your stomach, but they’re not,” Guest says. “They’re like tetanus shots — you’re a little sore afterwards but that’s it.”
Her dogs were in the middle of their three-year vaccination, and were taken in for their rabies booster shots the day after the initial contact. Additionally, they will need to be observed for the next 45 days.
Though shaken and exhausted by her ordeal, Guest is looking to educate other people to prevent them from making the same mistakes that she did. “I feel that it’s important for people to know the procedure for what to do and what not to do.”
If you find a suspicious or dead animal, Guest urges you to contact Animal Control or the police department, and to not make the same mistake that she did. “They have the expertise to deal with a potentially dangerous or even a fatal matter,” she said.
Peter Leung of the Bridgewater Department of Health stresses the importance of washing the wounds with soap and water after contact with an infected animal along with scheduling a doctor’s visit. “If you wash yourself or your dog or cat right away, it inactivates the virus right away.”
According to the NJ Department of Health, there have been a total of 250 cases of rabies in New Jersey since 2017.
Do NOT interact with a potentially hazardous animal.
Rabies Fact Sheet | Wagging Tail Walkabouts Pet Sitting
Source: New Jersey Department of Health
Group B streptococcus (STREP-toe-KAH-kiss) is a type of bacteria that is the most common cause of life-threatening infections in newborns: About 10% to 30% of pregnant women carry the GBS bacteria in their genital tracts, and pregnant women can pass GBS to their newborns shortly before or during delivery. It is the most common causes of sepsis (invasive infection). Two forms of GBS infection occur in newborns:
Early-onset symptoms usually are present within the first 24 hours of life (range: 0 to 6 days) and may include:
– Respiratory distress (gasping and difficulty breathing)
– Meningitis (swelling of the lining around the brain)
Late-onset conditions usually happen 3 to 4 weeks (range: 7 days to 3 months) of age, and symptoms include:
– Bacteremia (bacteria in the blood)
To prevent GBS in newborns, pregnant women should be screened for GBS at 35 to 37 weeks of pregnancy. If a health care provider suspects GBS, samples of the patient’s blood and/or spinal fluid will be examined. GBS infection is treated with antibiotics.
GBS can also occur in other age groups of both genders. In adults, GBS affects mostly the elderly and persons with chronic health problems and weak immune systems, causing infections of the urinary tract, blood, lungs, skin, soft tissue, bones, or joints.
To prevent GBS in adults, practice good hand washing habits (rubbing hands together under warm soapy water for at least 15 seconds), or use alcohol-based hand sanitizers.
Sources: KEYC News
Richard Kuhns of Oakhurst, New Jersey is a chemical engineer and author of How To Get Your Life Back From Morgellons, Chronic Lyme, And Other Skin Parasites. The book just went into its eighth edition, and he’s fed up with all the lies and deadly myths surrounding the controversial condition known as Morgellons disease, and is proud to announce that he is making it his mission to get the facts out.
In his studies of the disease since 1995, Kuhns has heard every rumor, myth, and assertion from Morgellons being an agent created by the Army for biological warfare to being an offshoot of Monsanto’s GMO program modifying our DNA. Meanwhile, the Centers for Disease Control (CDC) claim that it is a mental health issue — naming it delusional parasitosis — and not of organic origin. So, why take on this fight?
Kuhns answers, “Someone has got to curate the real news regarding Morgellons and keep them up-to-date with all the positive studies that help them get the treatment they so desperately need.” He wants sufferers of the disease not to lose hope when they are being bombarded with so much fake news they don’t know who to believe anymore. His book unravels the mysterious symptoms associated with Morgellons diseases and how to deal with them.
Because the symptoms are so bizarre, the medical community at large considers these patients to be suffering from a delusion that they’ve been infected by bugs, which Kuhns says “makes it that much tougher to weed out the wild conspiracy theories from real research going on behind the scenes. That’s why I have taken up the fight — to help those who suffer when no one else will.”
Kuhns continues, “Things have come a long way since then, but the dream of all these people is that the CDC wake up and do real research to verify Morgellons is of organic origin and the FDA wake up and get rid of Monsanto from rotating their executives in and out of the FDA. The desire is so great to achieve this that some people will do anything to link Morgellons to whatever pushes their agenda forward.”
It has been an uphill battle, especially when many of the leading researchers have dismissed his information. But Kuhns is in it for the long haul, stating: “It’s not about me, but those people who are suffering right now! I’ve been there and suffered skin parasites myself for a very long time.
“Since I have been at the forefront of Morgellons research, I believe I can steer patients away from the false claims and give them information that can aid in their recovery.”
“So why all this fuss over another office building?” asks John A. Fromhold, CEO of Hackensack Meridian Health’s Mountainside Medical Center, asked Tuesday.
For starters, the three-story, 45,735-square-foot facility will place 40 to 50 physicians directly across the street from the hospital, which has bordered Glen Ridge and Montclair since 1891.
These doctors’ expertise will include obstetrics and gynecology; internal medicine; family medicine; urology; general surgery; cardiology; orthopedics; ear-nose-throat care; pulmonology, and endocrinology, according to the property’s developer, Hampshire Cos. Additionally, pediatricians from Hackensack University Medical Center’s John M. Sanzari Children’s Hospital and 17 physician assistants will work in the complex.
The Glen Ridge office building is replacing the 120-year-old Mountainside Hospital School of Nursing facility, which occupied the site until 2015.
“Mountainside School was long considered the best in this region, and it trained more than 4,000 registered nurses, many of whom continue to work right here at Mountainside,” Fromhold proudly proclaimed.
As four-year bachelor’s degrees emerged for nursing, Mountainside partnered with Montclair State University, “which ensures that this community remains associated with nursing education,” the CEO noted.
“We’re going to really need, as part of a growing health care network, more ambulatory care centers and more medical office buildings that are very convenient and accessible for patients and their families,” the executive said. “Also, we need to make health care more affordable.
“I think the medical office building that’s going to be built behind me will accomplish all of those goals.”
“This new building will also us to fully optimize our space by replacing an antiquated building, and redeveloping and ideally situating on a site that has historical significance to Mountainside and its community,” Fromhold said.
The offices will be 100 percent pre-leased to Mountainside Medical Center upon their completion, which is anticipated in early 2020.
Additionally, Robert Garrett, co-CEO of Hackensack Meridian Health, couldn’t help but mention the Hackensack Meridian Health School of Medicine at Seton Hall University, which welcomed its first students on Monday on the ON3 campus in Nutley. The medical school’s “white coat ceremony,” marking the pupils’ transition into medical education, took place this week.
“I have some good news. We’re into Day Two, and all the students have gone to class both days,” Garrett quipped.
Imagine having recurrent physical symptoms that cause you discomfort, pain, and distress—then being told by the medical establishment that what you see and feel do not add up to a legitimate disease or syndrome.
That’s the experience of countless people convinced they are suffering from a real illness—such as singer-songwriter Joni Mitchell, who believes she has Morgellons disease, a questionable condition that makes people feel “fibers” or other objects poking out of their skin.
Symptoms include a sensation comparable to insects crawling under the skin, rashes caused by itching, tiredness and difficulty concentration. Some of those with the condition report seeing fibers or stringy material on their skin. However, there is not sufficient evidence to clarify whether it is a skin disorder or a psychological phenomenon.
Morgellons disease is also known as delusional infestation. It’s a divisive condition because some clinicians believe it should be treated with cognitive behavioral therapy, antidepressants and antipsychotic drugs, while others believe it could be caused by an infectious process in the skin.
Researchers at the Mayo Clinic and Aarhus University Hospital in Denmark believe tens of thousands of Americans could have the condition. In the first population-based study into delusional infestation, researchers pinpointed 35 cases between 1976 to 2010 in Minnesota’s Olmsted county. The scientists estimate between 27 out of every 100,000 people in the U.S. have delusional infestation.
Mayo Clinic dermatologist Dr. Mark Davis, who authored the study, says, “It’s like aliens have infested their skin.” And when lab tests confirm a patient’s body is not infested with insects, they may attempt to self-medicate in dangerous ways. Mental disorders such as schizophrenia and dementia can trigger the condition, as well as amphetamine use, he said.
A separate paper in the Annals of the Academy of Medicine detailed eight case studies of Chinese patients with delusional infestation, which lay bare the apparent distress of those who have the condition. The majority were female and over the age of 50. Clinicians treated the women with antipsychotics.
Chemical engineering scientist Richard Kuhns (of Oakhurst New Jersey), says: “Someone has got to curate the real news regarding Morgellons. Since I suffered with skin parasites and have been at the forefront of Morgellons research, I believe I can steer patients away from the false claims and give them information that can aid in their recovery.”
Editor’s Note: While Morgellons disease may very well turn out to be psychosomatic, I can remember when doctors said the exact same thing about menstrual cramps.
Governor Phil Murphy has announced that Teva Pharmaceuticals USA will locate its headquarters to Parsippany-Troy Hills, supporting more than 1,000 high-wage jobs in New Jersey, including the transfer and creation of more than 800 positions. Teva, a leading pharmaceutical company headquartered globally in Israel, had also considered several other locations to house its U.S. headquarters and commercial operations.
“The presence of global life sciences companies like Teva Pharmaceuticals is critical to New Jersey’s ability to strengthen a thriving innovation ecosystem,” said New Jersey governor Phil Murphy. “We are thrilled to expand our welcome to Teva, and its more than 1,000 employees, in the Garden State – the place to be for the world’s most competitive life sciences companies.”
Currently headquartered in North Wales, Pennsylvania, Teva Pharmaceuticals sought to consolidate its operations into a more centralized location to drive efficiencies and maximize the advantage of being part of a thriving life sciences cluster. The company, which will expand its existing Parsippany-Troy Hills location to nearly 350,000 square feet, expects to transfer and create 843 jobs and retain 232 existing positions. The median annual wage associated with the more than 1,000 positions is $128,073.
“Reducing the number of sites supports our drive to continue to improve productivity and efficiencies,” said Brendan O’Grady, Executive Vice President and Head of North America Commercial. “We’re pleased to expand our presence in New Jersey, having closer proximity to a vibrant business hub and a dynamic life sciences environment—all while increasing jobs and preserving many existing roles.”
Teva Pharmaceuticals USA is the North American arm of Teva Pharmaceuticals Industries Ltd., a leading global pharmaceutical company headquartered in Israel. The company has a global product portfolio of more than 1,800 molecules and a direct presence in 60 countries, including 30 locations across the U.S. and its territories. As a manufacturer of specialty and generic pharmaceuticals, Teva provides both new and innovative therapies and works to make quality healthcare accessible.
The New Jersey Economic Development Authority (EDA) approved performance-based tax credits through the Grow New Jersey (Grow NJ) program at its June 2018 board meeting.
“Nurturing the growth of strategic industry clusters is central to Governor Murphy’s mission of reclaiming New Jersey’s leadership in the innovation economy and strengthening the state’s economic competitiveness,” said Tim Sullivan, Chief Executive Officer of the EDA. “Teva’s long-term commitment to New Jersey is the latest evidence of the enduring strength of our life sciences industry and New Jersey’s value proposition to the world’s leading companies.